ClearPoint Neuro, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.34M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $16.18M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $93.57M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $0.00.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for fiscal 2024 was $16.18M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for fiscal 2021 was $46.78M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for fiscal 2019 was $7.43M.
- ClearPoint Neuro, Inc. stock issued during period, value, new issues for fiscal 2013 was $6.50M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $3.34M 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $16.18M 10-K · filed 2026-03-17 | |
| 2024-03-31 | $16.18M 10-Q · filed 2025-11-06 | |
| 2021-12-31 | $93.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $46.78M 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | -$93.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | $46.78M 10-Q · filed 2022-11-08 | |
| 2019-12-31 | $7.43M 10-K · filed 2021-03-22 | |
| 2019-06-30 | $7.43M 10-Q · filed 2020-11-12 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $6.50M 10-K · filed 2014-03-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | |
| 2013-03-31 | $6.50M 10-Q/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |